Company: SXTPW
Filing Date: 2025-07-07
Form Type: S-1
Source: 0001213900-25-061842
Chunk: 54

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-07-07
Form: S-1
Chunk 54
---
:|:--|
| Cash, cash equivalents and short-term investments                                                                                                                                                         |     | $      |   3,451,500 |   |     | $           |   7,632,931 |   |
| Total long-term liabilities                                                                                                                                                                               |     | $      |     146,502 |   |     | $           |     146,502 |   |
| Series A Preferred Stock, $0.0001 par value, 1,000,000 shares authorized; 76,480 issued and outstanding as of March 31, 2025, actual, 76,480 issued and outstanding, as adjusted                          |     | $      |   9,567,439 |   |     | $           |   9,567,439 |   |
| Common stock, $0.0001 par value; 150,000,000 shares authorized at March 31, 2025; 1,472,891 shares issued and outstanding at March 31, 2025, actual; 3,509,550 shares issued and outstanding, as adjusted |     | $      |         147 |   |     | $           |         351 |   |
| Additional paid-in capital                                                                                                                                                                                |     | $      |  36,821,588 |   |     | $           |  41,002,815 |   |
| Accumulated other comprehensive income                                                                                                                                                                    |     | $      |     125,567 |   |     | $           |     125,567 |   |
| Accumulated deficit                                                                                                                                                                                       |     | $      | (42,404,506 | ) |     | $           | (42,404,506 | ) |
| Total stockholders’ equity                                                                                                                                                                                |     | $      |   4,028,889 |   |     | $           |   8,210,320 |   |
| Total capitalization                                                                                                                                                                                      |     | $      |   4,175,391 |   |     | $           |   8,356,822 |   |

| (1) | The foregoing discussion and tables above are based on 1,472,891 shares of common stock outstanding as of March 31, 2025, and excludes: |

| ● | 57,068 shares of common stock reserved for future issuance under the 2022 Plan; |

| ● | 2,127,070 shares of common stock iss